Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Taliglucerase alfa

EU orphan designation number: EU/3/10/726   
Active ingredient: Taliglucerase alfa
Indication: Treatment of Gaucher Disease
Sponsor: Pfizer Limited
Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/03/2010 Orphan designation EMEA/OD/125/09 (2010)2051 of 23/03/2010
30/09/2010 Transfer of orphan designation EMEA/OD/125/09/T/01 (2010)6813 of 28/09/2010